Redox-Active Molecules as Therapeutic Agents
Oxidative stress and altered redox signaling have been described in a plethora of pathological conditions. Redox-active molecules can thus potentially be used to modulate the etiology/progression of such diseases. Recent advances in molecular biology and pharmacology have strengthened this area of r...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 04405namaa2201261uu 4500 | ||
|---|---|---|---|
| 001 | doab87539 | ||
| 003 | oapen | ||
| 005 | 20220706 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 220706s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036543819 | ||
| 020 | |a 9783036543826 | ||
| 020 | |a books978-3-0365-4382-6 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-4382-6 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a GP |2 bicssc | |
| 072 | 7 | |a PS |2 bicssc | |
| 720 | 1 | |a Fernandes, Ana Sofia |4 edt | |
| 720 | 1 | |a Fernandes, Ana Sofia |4 oth | |
| 245 | 0 | 0 | |a Redox-Active Molecules as Therapeutic Agents |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 online resource (266 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a Oxidative stress and altered redox signaling have been described in a plethora of pathological conditions. Redox-active molecules can thus potentially be used to modulate the etiology/progression of such diseases. Recent advances in molecular biology and pharmacology have strengthened this area of research by providing novel mechanistic insights. This book compiles a collection of 13 articles, covering a range of topics from in vitro studies to clinical research, focused on the potential therapeutic effects of either natural or synthetic compounds, applicable to different redox-related diseases. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Biology, life sciences |2 bicssc | |
| 650 | 7 | |a Research and information: general |2 bicssc | |
| 653 | |a (poly)phenols | ||
| 653 | |a adipose-derived mesenchymal stem cell | ||
| 653 | |a amniotic membrane-derived mesenchymal stem cell | ||
| 653 | |a antioxidant capacity | ||
| 653 | |a antioxidants | ||
| 653 | |a apoptosis | ||
| 653 | |a apurinic/apyrimidinic endonuclease 1 | ||
| 653 | |a assisted reproductive technology | ||
| 653 | |a ATF4 | ||
| 653 | |a BAPN | ||
| 653 | |a bioactivity-based assays | ||
| 653 | |a breast cancer | ||
| 653 | |a cancer therapy | ||
| 653 | |a cardiorenal syndrome | ||
| 653 | |a carnosic acid | ||
| 653 | |a CD IGS rats | ||
| 653 | |a cell cycle | ||
| 653 | |a cell invasion | ||
| 653 | |a chemoresistance | ||
| 653 | |a cisplatin | ||
| 653 | |a conditioned medium | ||
| 653 | |a curcumin | ||
| 653 | |a cyanidin | ||
| 653 | |a Cysteamine | ||
| 653 | |a cytotoxicity | ||
| 653 | |a DNA damage | ||
| 653 | |a doxorubicin | ||
| 653 | |a E3330 | ||
| 653 | |a embryo | ||
| 653 | |a EMT | ||
| 653 | |a glutathione peroxidase | ||
| 653 | |a glutathione reductase | ||
| 653 | |a GSH | ||
| 653 | |a H2S donors | ||
| 653 | |a hydrogen sulfide | ||
| 653 | |a hypercholesterolemia | ||
| 653 | |a in vitro culture | ||
| 653 | |a in vitro fertilization | ||
| 653 | |a inhibitors | ||
| 653 | |a invasion | ||
| 653 | |a KEAP1 | ||
| 653 | |a lactic acid bacteria | ||
| 653 | |a lysyl-oxidase | ||
| 653 | |a lysyl-oxidase like 2 | ||
| 653 | |a metabolomics | ||
| 653 | |a metastases | ||
| 653 | |a migration | ||
| 653 | |a mitochondrial reactive oxygen species | ||
| 653 | |a N-acetyl cysteine | ||
| 653 | |a n/a | ||
| 653 | |a non-small cell lung cancer | ||
| 653 | |a NRF2 | ||
| 653 | |a nuclear factor erythroid 2-related factor 2 (Nrf2) | ||
| 653 | |a oxidative stress | ||
| 653 | |a OxPhos | ||
| 653 | |a peroxiredoxin 3 | ||
| 653 | |a pro-oxidant therapy | ||
| 653 | |a prostate cancer | ||
| 653 | |a reactive oxygen species | ||
| 653 | |a redox signaling | ||
| 653 | |a Rubus genus | ||
| 653 | |a selenium-enriched Enterococcus faecium | ||
| 653 | |a selenium-enriched Streptococcus thermophilus | ||
| 653 | |a SGK1 | ||
| 653 | |a sildenafil | ||
| 653 | |a systemic sclerosis | ||
| 653 | |a thiostrepton | ||
| 653 | |a thiosulfate | ||
| 653 | |a verbascoside | ||
| 653 | |a withanolide | ||
| 653 | |a yeast-based discovery platform | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/87539 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/5737 |7 0 |z Open Access: DOAB, download the publication |